Two Clinical-Stage Firms Rallied Yesterday
On a day when the Stock Market was crushed, taking down with it shareholders’ money for no reason other than the self-serving untouchable agendas, two small biotechnology companies staged rallies.
Atea Pharmaceuticals and Xenon Pharmaceuticals deserved the boosting of their stocks.
Atea Pharmaceuticals (AVIR) - a clinical-stage biopharmaceutical company, reported for the first time . . .